Deregulated ephrin-B2 expression in the mammary gland interferes with the development of both the glandular epithelium and vasculature and promotes metastasis formation

International Journal of Oncology

Volumn 35, Issue 3, 2009, Pages 525-536

  Haldimann, Mirjam ^a   Custer, Domenica ^a   Munarini, Nadia ^a   Stirnimann, Christoph ^a   Zürcher, Gisela ^a   Rohrbach, Valeria ^a   Djonov, Valentin ^b   Ziemiecki, Andrew ^a   Andres, Anne Catherine ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Angiogenesis; Carcinogenesis; Dominant negative mutant; Eph ephrin forward reverse signalling; Mammary epithelium; Metastasis

Indexed keywords

EPHRIN B2; NEUT PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; BREAST EPITHELIUM; BREAST TUMOR; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; LACTATION; METASTASIS; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE DIFFERENTIATION; TRANSGENIC MOUSE; TUMOR GROWTH;

ANIMALS; EPHRIN-B2; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 70349123098     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000364     Document Type: Article

References (55)

1. Richert MM, Schwertfeger KL, Rydner JW and Anderson SM: An atlas of mouse mammary gland development. J Mamm Gland Biol Neopl 5: 227-242, 2000.
2. Djonov V, Andres A-C and Ziemiecki A: Vascular remodelling during the normal and malignant life cycle of the mammary gland. Micr Res Tech 52: 182-190, 2001.
3. Russo J, Fu Hu Y, Silva IDCG and Russo IH: Cancer risk related to mammary gland structure and development. Micr Res Tech 52: 204-224, 2001.
4. Schmeichel KL, Weaver VM and Bissell M: Structural cues from tissue microenvironment are essential determinants of the human mammary epithelial phenotype. J Mamm Gland Biol Neopl 3: 201-214, 1998.
5. Stingl J and Caldas C: Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 7: 791-799, 2007.
6. Friedmann Y, Daniel CA, Strickland P and Daniel CW: Hox genes in normal and neoplastic mouse mammary gland. Cancer Res 54: 5981-5985, 1994.
7. Gavin BJ and McMahon AP: Differential regulation of the wnt gene family during pregnancy and lactation suggests a role in post-natal development of the mammary gland. Mol Cell Biol 12: 2418-2423, 1992.
8. Holder N and Klein R: Eph receptors and ephrins: effectors of morphogenesis. Development 126: 2033-2044, 1999.
9. Andres A-C and Ziemiecki A: Eph and ephrin signalling in mammary gland morphogenesis and cancer. J Mamm Gland Biol Neopl 8: 475-486, 2003.
10. Pasquale EB: EPH receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 6: 462-475, 2005.
11. Dodelet VC and Pasquale EB: Eph receptors and ephrin ligands: embryogenesis to tumorigenesis. Oncogene 19: 1097-1101, 2000.
12. Hattori M, Osterfield M and Flanagan JG: Regulated cleavage of contact-mediated axon repellent. Science 289: 1360-1365, 2000.
13. Zimmer M, Palmer A, Kohler J and Klein R: EphB-ephrin-B bi-directional endocytosis terminates adhesion allowing contact mediated repulsion. Nat Cell Biol 5: 869-878, 2003.
14. Marston DJ, Dickinson S and Nobes CD: Rac dependent transendocytosis of ephrinBs regulates Eph-ephrin contact repulsion. Nat Cell Biol 5: 879-888, 2003.
15. Lackmann M and Boyd AW: Eph, a protein family coming of age: more confusion, insight or complexity? Sci Signal 1: re2, 2008.
16. Murai KK and Pasquale EB: 'Eph' ective signalling: forward, reverse and crosstalk. J Cell Sci 116: 2823-2832, 2003.
17. Janes PW, Adikari S and Lackmann M: Eph/ephrin signalling and function in oncogenesis: lessons from embryonic development. Curr Cancer Drug Targets 8: 473-479, 2008.
18. Adams RH: Molecular control of arterial-venous blood vessel identity. J Anat 202: 105-112, 2003.
19. Andres A-C, Reid HH, Zürcher G, Blaschke R, Albrecht D and Ziemiecki A: Expression of two novel eph-related receptor tyrosine kinases in mammary gland development and carcinogenesis. Oncogene 9: 1461-1467, 1994.
20. Shin D, Garcia-Gardena G, Hayashi S-I, Gerety S, Asahara T, Stavrakis G, Isner J, Folkmann J, Gimbrone MA and Anderson DJ: Expression of ephrin-B2 identifies a stable genetic difference between arterial and venous vascular smooth muscle cells as well as endothelial cells and marks subsets of microvessels at sites of neovascuarisation. Dev Biol 230: 139-150, 2001.
21. Batlle E, Bacani J, Begthel H, et al: EphB receptor activity suppresses colorectal cancer progression. Nature 435: 1126-1130, 2005.
22. Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T, Suda T and Matsuo K: Bidirectional ephrin-B2-EphB4 signalling controls bone homeostasis. Cell Metab 4: 111-121, 2006.
23. Okubo T, Yanai N and Obinata M: Stromal cells modulate ephrin-B2 expression and transmigration of hematopoietic cells. Exp Hematol 34: 330-338, 2006.
24. Pasquale EB: Eph-ephrin bidirectional signalling in physiology and disease. Cell 133: 38-52, 2008.
25. Nikolova Z, Djonov V, Zürcher G, Andres A-C and Ziemiecki A: Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and ist ligand ephrin-B2 during mammary gland morphogenesis. J Cell Sci 111: 2741-2751, 1998.
26. Munarini N, Jäger R, Abderhalden S, Zürcher G, Rohrbach V, Lörcher S, Pfanner-Meyer B, Andres A-C and Ziemiecki A: Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase. J Cell Sci 115: 25-37, 2002.
27. Andres A-C, Bchini O, Schubaur B, Dolder B, LeMeur M and Gerlinger P: Ha-ras induced transformation of mammary epithelium is favoured by increased oncogene expression or inhibition of mammary regression. Oncogene 6: 771-779, 1991.
28. Küng P, Nikolova Z, Djonov V, Hemphill A, Rohrbach V, Boehlen D, Zürcher G, Andres A-C and Ziemiecki A: A novel family of serine/ threonine kinases participaring in spermiogenesis. J Cell Biol 139: 1851-1859, 1997.
29. Djonov V, Schmid M, Tschanz AA and Burri PH: Intussusceptive angiogenesis: its role in embryonic vascular network formation. Circ Res 86: 286-292, 2000.
30. Hennighausen L: Mouse models for breast cancer. Oncogene 19: 966-967, 2000.
31. Cowan CA, Yokoyama N, Saxena A, Chumley MJ, Silvany RE, Baker LA, Srivastava D and Henkemeyer M: Ephrin-B2 reverse signalling is required for axon pathfinding but not early vascular development. Dev Biol 271: 263-271, 2004.
32. Fuller T, Korff T, Kilian A, Dandekar G and Augustin HG: Forward EphB4 signalling in endothelial cells controls cellular repulsion and segregation from ephrin-B2 positive cells. J Cell Sci 116: 2461-2470, 2003.
33. Adams RH, Diella F, Hennig S, Helmbacher F, Deutsch U and Klein R: The cytoplasmic domain of the ligand ephrin-B2 is required for vascular morphogenesis but not cranial neural crest migration. Cell 104: 57-69, 2001.
34. LaMarca H and Rosen J: Minireview: Hormones and mammary cell fate - what will I become when I grow up? Endocrinology 149: 4317-4321, 2008.
35. Kullander K and Klein R: Mechanisms and functions of Eph and ephrin signalling. Nat Rev 3: 475-486, 2002.
36. Schatzmann F, Marlow R and Streuli C: Integrin signalling and mammary gland function. J Mamm Gland Biol Neopl 8: 395-408, 2003.
37. Jackson D, Bresnick J and Dickson C: A role for fibroblast growth factor signalling in the lobuloalveolar development of the mammary gland. J Mamm Gland Biol Neopl 2: 385-392, 1997.
38. Meniel V and Clarke AR: Wnt-cadherin connections in normal and neoplastic mammary epithelium. J Mamm Gland Biol Neopl 8: 435-448, 2003.
39. Daniel CW, Strickland P and Freemann Y: Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth. Dev Biol 169: 511-519, 1995.
40. Orsulic S and Kemler R: Expression of Eph receptors and ephrins is differentially regulated by E-cadherin. J Cell Sci 113: 1793-1802, 2000.
41. Zantek ND, Walker-Daniels J, Stewart J, Hansen RK, Robinson D, Miao H, Wang B, Kung HJ, Bisselll MJ and Kinch MS: MCF-10A-neoST: a new cell system for studying cell-ECM and cell-cell interactions in breast cancer. Clin Cancer Res 7: 3640-3648, 2001.
42. Boussaida O, Kutsch S, Hierholzer A, Delmas V and Kemler R: E-cadherin is a survival factor for the lactating mouse mammary gland. J Mech Dev 115: 53-62, 2002.
43. Héroult M, Schaffner F and Augustin HG: Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression. Exp Cell Res 312: 642-650, 2006.
44. Zisch AH, Zeisberger SM, Ehrbar M, Djonov V, Weber CC, Ziemiecki A, Pasquale EB and Hubbell JA: Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signalling by ephrin-B2. Biomaterials 25: 3245-3257, 2004.
45. Malathy P, Shekar, V, Werdell J and Tait L: Interaction with endothelial cells is a prerequisite for branching-ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen. Cancer Res 60: 439-449, 2000.
46. Shekar MP, Werdell J, Santner SJ, Pauley RJ and Tait L: Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res 61: 1320-1326, 2001.
47. Noren NK, Lu M, Freeman AL, Koolpe M and Pasquale EB: Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor grpwth. Proc Natl Acad Sci USA 110: 5583-5588, 2004.
48. Noren NK, Foos G, Hauser CA and Pasquale EB: The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol 8: 815-825, 2006.
49. Alam SM, Fujimoto J, Jahan I, Sato E and Tamaya T: Coexpression of EphB4 and ephrin-B2 in tumor advancement of ovarian cancer. Br J Cancer 98: 845-851, 2008.
50. Alam SM, Fujimoto J, Jahan I, Sato E and Tamaya T: Overexpression of ephrin-B2 and EphB4 in tumor advancement of uterine endometrial cancer. Ann Oncol 18: 485-490, 2007.
51. Berclaz G, Karamitopoulou E, Mazzucchelli L, Rohrbach V, Dreher E, Ziemiecki A and Andres A-C: Activation of the receptor tyrosine kinase EphB4 in endometrial hyperplasia and endometrial carcinoma. Ann Oncol 14: 220-226, 2003.
52. Walker-Daniels J, Hess AR, Hendrix MJ and Kinch MS: Differential regulation of EphA2 in normal and malignant cells. Am J Pathol 162: 1037-1042, 2003.
53. Zantek ND, Azimi M, Fedor-Chaiken M, Wang B, Brackenbury R and Kinch MS: E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differ 10: 629-638, 1999.
54. Zelinsky DP, Zantek ND, Stewart JC, Irizarry AR and Kinch MS: EphA2 overexpression causes tumorigenesis of mammary epithelial cells. Cancer Res 61: 2301-2306, 2001.
55. Ogawa K, Pasqualini R, Lindberg RA, Kain R, Freeman AR and Pasquale EB: The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene 19: 6043-6052, 2000.